7gmM

Inflation Watch: China PPI, Empire Prices, NFIB Survey

Summary:  Momentum continues to build across a suite of inflationary reads. We run through the latest in global survey data and the read through for inflation.


Although the move higher in long dated yields in the US has stabilised since our last Inflation Watch update there is no shortage in inflationary reads and pricing pressures across various survey data. Eurozone yields have picked up the baton and are pushing higher and as the growth backdrop continues to improve alongside strengthening inflation expectations UST yields will soon follow suit, resuming their march higher toward 2%.

The good news continues to roll in for growth with a slew of positive economic data delivered in recent weeks. Granted favourable base effects are playing their part in the year over year acceleration in the data (and will continue to do so) but on some measures 2019 levels are being surpassed. All told the economic cycle continues to accelerate which remains the driving force propelling equity markets in the near term.

However, once that rate of change turns, focus will likely shift to the impact of rising input costs and widespread price pressures and the prospect taxes hikes – likely a more difficult period to navigate. Remember, everything happens at the second derivative!

China PPI

Rising PPI inflation in China could drive US CPI inflation materially higher and is another indicator of price pressures. Through March the China producer price index rose 4.4% from a year earlier, and 1.6% from the prior month.

Base effects have contributed to this move higher but are not the full story. Increases in prices across almost the entire commodity complex, from copper, coal, and oil, to battery metals and rare earths, is hitting factory gate prices. The impact of increased prices across the commodity complex will continue to flow through to PPI over the coming months, as will base effects continue to contribute to higher PPI reads. As the effect of increased commodity prices continues to flow through to PPI inflation we could see this number heading toward 10% in the coming months.

02_ELEC_1
Source: Bloomberg

An uptick in factory gate prices in China has historically held a close relationship and high positive correlation with US headline CPI. As supply side bottlenecks build, demand picks up and input prices continue to move higher, output prices will likely follow.

02_ELEC_2
Source: Bloomberg, Saxo Capital Markets

NFIB Small Business Survey

According to the survey 34% of firms plan to increase selling prices. The last time this survey read was seen, headline CPI was printing above 5% YoY. It is clear pandemic fatigued consumers with fiscally bolstered incomes and high savings are ready to spend. Confidence is on the up, the labour market recovery is underway and household spending expectations are close to all time highs. Against this backdrop, and with the added impact of rising input costs due to raw materials inflation and supply chain disruptions it is reasonable to expect some pass through to end-user prices.

The NFIB small business survey of job hard to fill has accelerated to an all-time high in March as business report having trouble filling jobs at the fastest pace on record. Small businesses are potentially in competition with enhanced unemployment benefits here, so it is difficult to draw firm conclusions, but it is possible that businesses will have to up the ante in enticing people back to work.

Empire State Manufacturing Survey

Input price increases continued to pick up in March relative to February, rising at the fastest pace in nearly a decade, and selling prices increased significantly.

02_ELEC_3
Source: Bloomberg

US ISM Manufacturing PMI

Continues to indicate momentum in price pressures. The survey's measure of prices paid by manufacturers fell slightly from February to a reading of 85.60, vs. 86.00 in February which was the highest since July 2008. Indicating price pressures remain elevated hovering near levels last seen in 2008. The forward-looking new orders sub-index leapt to 68.0 in March - the highest reading since January 2004.

Against incoming easier comparisons (base effects plunge into heart of pandemic) and Covid-fatigued consumers that are vaccinated and ready to spend, inflation will soon be higher. Transfers have bolstered incomes, the labour market is rebounding, savings are elevated and in the US household spending expectations are high. In addition, consumer confidence is on the up. This increase in demand will quickly meet supply constraints and the base effect cliff. Markets have recognised this shift, but inflation is likely to more than “moderately overshoot” based on our methodologies, which is not sufficiently discounted yet.

New York Fed's Survey of Consumer Expectations

It’s not just investors expecting higher inflation, but consumers too. Consumers' expectations for price inflation are the highest in 7 years. Inflation expectations are what people expect future inflation to be, and to some degree realised inflation is governed by inflation expectations. This as economic agents alter their behaviours today based on the expectation that inflation will be higher (or lower) in the future. The data show consumers clearly see inflation rising materially above 2%.

What is the Fed watching?

Recently Fed Vice Chair Clarida, pointed to a measure of inflation expectations closely watched by the Committee. The measure is the “Estimated index of common inflation expectations” and combines various market and survey measures into a single index of households and businesses expectations for price inflation.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.